Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Phil on +44 1494 818 008 or phil@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Phil Hardy
Senior Account Manager
phil@zenopa.com
+44 1494 818 008

Testimonials
I have say that Zenopa were extremely professional and were a thorough consultancy to work with and I was always impressed with their attention to detail.
Mark, 2013

Bayer HealthCare sales forecast for growth up to 2014

14 March 2012 00:00 in Pharmaceutical Company Financials


Bayer HealthCare has been forecast to reach an annual sales total of 20 billion euros (16.64 billion pounds) by 2014.

During a recent investor conference, the Bayer group's chief executive officer Dr Marijn Dekkers predicted that the business unit will experience growth in terms of revenues and margins, thanks to the strength of its pipeline.

Financial data for 2011 released last month showed that Bayer HealthCare sales came to 17.17 billion euros last year, helping to drive a 4.1 percent year-on-year rise in revenues for the group as a whole.

Sales predictions for a number of key therapies have recently been increased, with Bayer believing that its late-stage developmental drugs Xarelto, VEGF Trap-Eye, Alpharadin and regorafenib all have billion-dollar blockbuster potential.

The company aims to build on this by continuing its expansion in emerging markets, a key area of growth in 2011.

"Our innovations and their successful commercialisation are the foundation for this company's continued growth," added Dr Dekkers.ADNFCR-8000103-ID-801317182-ADNFCR

Other news stories from 14/03/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd